Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma (clinicaltrials.gov) - Oct 16, 2026 - P2 | N=30 | Recruiting | Sponsor: University of Washington | Not yet recruiting ➔ Recruiting
Enrollment open • Follicular Lymphoma • Hematological Malignancies • Oncology
|